Try our Advanced Search for more refined results
July 10, 2013
UCB Inc. et al v. Accord Healthcare Inc. et al
Case Number:
1:13-cv-01206
Court:
Nature of Suit:
Judge:
Firms
- Blank Rome
- Heyman Enerio
- Morris James
- Morris Nichols
- Murphy Spadaro & Landon
- Perkins Coie
- Phillips McLaughlin
- Richards Layton
- Shaw Keller
- Young Conaway
Companies
- Alembic Pharmaceuticals Ltd.
- Allergan PLC
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Breckenridge Pharmaceutical Inc.
- Cadila Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hetero Labs Ltd.
- Ranbaxy
- Research Corporation Technologies Inc.
- Sandoz International GmbH
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
- Viatris Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 16, 2016
UCB's Anti-Convulsant Patent Is Valid, Delaware Judge Rules
A UCB Inc. patent for the anti-convulsant Vimpat is valid, a Delaware federal judge said in an opinion unsealed on Monday, blocking attempts by Actavis Inc., Mylan Pharmaceuticals Inc., Apotex Inc.. and several other drugmakers to make and sell a generic versison of the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login